nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—ADRA2A—type 2 diabetes mellitus	0.156	0.521	CbGaD
Amoxapine—HTR2C—type 2 diabetes mellitus	0.144	0.479	CbGaD
Amoxapine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0421	0.0984	CbGbCtD
Amoxapine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0409	0.0957	CbGbCtD
Amoxapine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0369	0.0863	CbGbCtD
Amoxapine—ORM1—Nateglinide—type 2 diabetes mellitus	0.0342	0.08	CbGbCtD
Amoxapine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.033	0.0771	CbGbCtD
Amoxapine—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0323	0.0755	CbGbCtD
Amoxapine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0304	0.0711	CbGbCtD
Amoxapine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0293	0.0685	CbGbCtD
Amoxapine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0215	0.0502	CbGbCtD
Amoxapine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0202	0.0473	CbGbCtD
Amoxapine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0193	0.0452	CbGbCtD
Amoxapine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0193	0.0452	CbGbCtD
Amoxapine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0185	0.0434	CbGbCtD
Amoxapine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0178	0.0417	CbGbCtD
Amoxapine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00936	0.0219	CbGbCtD
Amoxapine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00864	0.0202	CbGbCtD
Amoxapine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00709	0.0166	CbGbCtD
Amoxapine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0068	0.0159	CbGbCtD
Amoxapine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00246	0.0707	CbGeAlD
Amoxapine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00237	0.0681	CbGeAlD
Amoxapine—HTR2A—arteriole—type 2 diabetes mellitus	0.00232	0.0667	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00166	0.0475	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.0016	0.0458	CbGeAlD
Amoxapine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00148	0.0425	CbGeAlD
Amoxapine—DRD1—nerve—type 2 diabetes mellitus	0.00144	0.0412	CbGeAlD
Amoxapine—HTR3A—nerve—type 2 diabetes mellitus	0.00139	0.0398	CbGeAlD
Amoxapine—HTR1B—artery—type 2 diabetes mellitus	0.00117	0.0337	CbGeAlD
Amoxapine—SLC6A3—nerve—type 2 diabetes mellitus	0.00115	0.0331	CbGeAlD
Amoxapine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00115	0.0331	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000995	0.0286	CbGeAlD
Amoxapine—SLC6A2—nerve—type 2 diabetes mellitus	0.000931	0.0267	CbGeAlD
Amoxapine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00092	0.0264	CbGeAlD
Amoxapine—HTR7—artery—type 2 diabetes mellitus	0.000905	0.026	CbGeAlD
Amoxapine—HTR7—nerve—type 2 diabetes mellitus	0.000898	0.0258	CbGeAlD
Amoxapine—DRD2—nerve—type 2 diabetes mellitus	0.000849	0.0244	CbGeAlD
Amoxapine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000844	0.0242	CbGeAlD
Amoxapine—HTR7—endothelium—type 2 diabetes mellitus	0.000764	0.0219	CbGeAlD
Amoxapine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000718	0.0206	CbGeAlD
Amoxapine—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000672	0.0193	CbGeAlD
Amoxapine—HTR2A—artery—type 2 diabetes mellitus	0.000564	0.0162	CbGeAlD
Amoxapine—HTR2A—nerve—type 2 diabetes mellitus	0.00056	0.0161	CbGeAlD
Amoxapine—HTR2A—endothelium—type 2 diabetes mellitus	0.000477	0.0137	CbGeAlD
Amoxapine—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000408	0.0117	CbGeAlD
Amoxapine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000369	0.0106	CbGeAlD
Amoxapine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000367	0.0105	CbGeAlD
Amoxapine—DRD2—retina—type 2 diabetes mellitus	0.000351	0.0101	CbGeAlD
Amoxapine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.00035	0.01	CbGeAlD
Amoxapine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000329	0.00945	CbGeAlD
Amoxapine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000324	0.0093	CbGeAlD
Amoxapine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000319	0.00915	CbGeAlD
Amoxapine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000314	0.00903	CbGeAlD
Amoxapine—HTR7—kidney—type 2 diabetes mellitus	0.000308	0.00883	CbGeAlD
Amoxapine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000303	0.00871	CbGeAlD
Amoxapine—Desloratadine—CYP1A2—type 2 diabetes mellitus	0.000293	0.0989	CrCbGaD
Amoxapine—Asenapine—ADRA2A—type 2 diabetes mellitus	0.000272	0.0918	CrCbGaD
Amoxapine—ORM1—liver—type 2 diabetes mellitus	0.000269	0.00772	CbGeAlD
Amoxapine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000267	0.00768	CbGeAlD
Amoxapine—Asenapine—HTR2C—type 2 diabetes mellitus	0.00025	0.0845	CrCbGaD
Amoxapine—HTR2A—retina—type 2 diabetes mellitus	0.000232	0.00665	CbGeAlD
Amoxapine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000224	0.00643	CbGeAlD
Amoxapine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.00022	0.00631	CbGeAlD
Amoxapine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000207	0.00594	CbGeAlD
Amoxapine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000203	0.00584	CbGeAlD
Amoxapine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000196	0.00563	CbGeAlD
Amoxapine—HTR7—liver—type 2 diabetes mellitus	0.000194	0.00558	CbGeAlD
Amoxapine—HTR2A—kidney—type 2 diabetes mellitus	0.000192	0.00551	CbGeAlD
Amoxapine—Asenapine—CYP1A2—type 2 diabetes mellitus	0.000189	0.0637	CrCbGaD
Amoxapine—ADRA1A—liver—type 2 diabetes mellitus	0.000188	0.00538	CbGeAlD
Amoxapine—CYP2D6—kidney—type 2 diabetes mellitus	0.000175	0.00502	CbGeAlD
Amoxapine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	0.000159	0.0536	CrCbGaD
Amoxapine—Olanzapine—ADRA2A—type 2 diabetes mellitus	0.000151	0.051	CrCbGaD
Amoxapine—Olanzapine—HTR2C—type 2 diabetes mellitus	0.000139	0.047	CrCbGaD
Amoxapine—Alopecia—Losartan—type 2 diabetes mellitus	0.000125	0.000912	CcSEcCtD
Amoxapine—Asenapine—CYP3A4—type 2 diabetes mellitus	0.000125	0.0422	CrCbGaD
Amoxapine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000125	0.000911	CcSEcCtD
Amoxapine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000125	0.000908	CcSEcCtD
Amoxapine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000125	0.000907	CcSEcCtD
Amoxapine—Syncope—Metformin—type 2 diabetes mellitus	0.000124	0.000907	CcSEcCtD
Amoxapine—Oedema—Valsartan—type 2 diabetes mellitus	0.000124	0.000906	CcSEcCtD
Amoxapine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000124	0.000905	CcSEcCtD
Amoxapine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000124	0.000904	CcSEcCtD
Amoxapine—Rash—Glipizide—type 2 diabetes mellitus	0.000123	0.0009	CcSEcCtD
Amoxapine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000123	0.000899	CcSEcCtD
Amoxapine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000123	0.000899	CcSEcCtD
Amoxapine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000123	0.000898	CcSEcCtD
Amoxapine—Oedema—Orlistat—type 2 diabetes mellitus	0.000123	0.000895	CcSEcCtD
Amoxapine—Headache—Glipizide—type 2 diabetes mellitus	0.000123	0.000894	CcSEcCtD
Amoxapine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000123	0.000894	CcSEcCtD
Amoxapine—Palpitations—Metformin—type 2 diabetes mellitus	0.000123	0.000894	CcSEcCtD
Amoxapine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000122	0.000892	CcSEcCtD
Amoxapine—Shock—Valsartan—type 2 diabetes mellitus	0.000122	0.000891	CcSEcCtD
Amoxapine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000122	0.000889	CcSEcCtD
Amoxapine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000122	0.000887	CcSEcCtD
Amoxapine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000122	0.000886	CcSEcCtD
Amoxapine—Flatulence—Losartan—type 2 diabetes mellitus	0.000121	0.000885	CcSEcCtD
Amoxapine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000121	0.000884	CcSEcCtD
Amoxapine—HTR2A—liver—type 2 diabetes mellitus	0.000121	0.00348	CbGeAlD
Amoxapine—Tension—Losartan—type 2 diabetes mellitus	0.000121	0.000881	CcSEcCtD
Amoxapine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000121	0.000881	CcSEcCtD
Amoxapine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000121	0.000879	CcSEcCtD
Amoxapine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000878	CcSEcCtD
Amoxapine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00012	0.000877	CcSEcCtD
Amoxapine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00012	0.000877	CcSEcCtD
Amoxapine—Hypertension—Metformin—type 2 diabetes mellitus	0.00012	0.000873	CcSEcCtD
Amoxapine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00012	0.000873	CcSEcCtD
Amoxapine—Nervousness—Losartan—type 2 diabetes mellitus	0.00012	0.000872	CcSEcCtD
Amoxapine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000119	0.000868	CcSEcCtD
Amoxapine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000119	0.000868	CcSEcCtD
Amoxapine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000119	0.000864	CcSEcCtD
Amoxapine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000862	CcSEcCtD
Amoxapine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000118	0.000857	CcSEcCtD
Amoxapine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000117	0.000856	CcSEcCtD
Amoxapine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000854	CcSEcCtD
Amoxapine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000117	0.00085	CcSEcCtD
Amoxapine—Nausea—Glipizide—type 2 diabetes mellitus	0.000116	0.000848	CcSEcCtD
Amoxapine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000116	0.000847	CcSEcCtD
Amoxapine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000116	0.000847	CcSEcCtD
Amoxapine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000116	0.000846	CcSEcCtD
Amoxapine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000844	CcSEcCtD
Amoxapine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000116	0.000843	CcSEcCtD
Amoxapine—Tremor—Losartan—type 2 diabetes mellitus	0.000115	0.000841	CcSEcCtD
Amoxapine—Rash—Glimepiride—type 2 diabetes mellitus	0.000115	0.00084	CcSEcCtD
Amoxapine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000115	0.000839	CcSEcCtD
Amoxapine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000115	0.000839	CcSEcCtD
Amoxapine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000837	CcSEcCtD
Amoxapine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000836	CcSEcCtD
Amoxapine—Headache—Glimepiride—type 2 diabetes mellitus	0.000114	0.000834	CcSEcCtD
Amoxapine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000832	CcSEcCtD
Amoxapine—Agitation—Losartan—type 2 diabetes mellitus	0.000113	0.000825	CcSEcCtD
Amoxapine—Oedema—Metformin—type 2 diabetes mellitus	0.000113	0.000825	CcSEcCtD
Amoxapine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000113	0.000825	CcSEcCtD
Amoxapine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000113	0.000824	CcSEcCtD
Amoxapine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000822	CcSEcCtD
Amoxapine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000112	0.00082	CcSEcCtD
Amoxapine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000112	0.000814	CcSEcCtD
Amoxapine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000112	0.000813	CcSEcCtD
Amoxapine—Shock—Metformin—type 2 diabetes mellitus	0.000111	0.000812	CcSEcCtD
Amoxapine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000111	0.00081	CcSEcCtD
Amoxapine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000111	0.000808	CcSEcCtD
Amoxapine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.000806	CcSEcCtD
Amoxapine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000111	0.000806	CcSEcCtD
Amoxapine—Syncope—Losartan—type 2 diabetes mellitus	0.000111	0.000805	CcSEcCtD
Amoxapine—CYP2D6—liver—type 2 diabetes mellitus	0.00011	0.00317	CbGeAlD
Amoxapine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00011	0.000804	CcSEcCtD
Amoxapine—Leukopenia—Losartan—type 2 diabetes mellitus	0.00011	0.000804	CcSEcCtD
Amoxapine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000109	0.000798	CcSEcCtD
Amoxapine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000795	CcSEcCtD
Amoxapine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000109	0.000794	CcSEcCtD
Amoxapine—Palpitations—Losartan—type 2 diabetes mellitus	0.000109	0.000794	CcSEcCtD
Amoxapine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000109	0.000791	CcSEcCtD
Amoxapine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000108	0.000789	CcSEcCtD
Amoxapine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000789	CcSEcCtD
Amoxapine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000108	0.000788	CcSEcCtD
Amoxapine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000108	0.000788	CcSEcCtD
Amoxapine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000108	0.000788	CcSEcCtD
Amoxapine—Anorexia—Metformin—type 2 diabetes mellitus	0.000108	0.000787	CcSEcCtD
Amoxapine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000108	0.000784	CcSEcCtD
Amoxapine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000107	0.000782	CcSEcCtD
Amoxapine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000107	0.000781	CcSEcCtD
Amoxapine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.00078	CcSEcCtD
Amoxapine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000107	0.00078	CcSEcCtD
Amoxapine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000107	0.000779	CcSEcCtD
Amoxapine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000107	0.000778	CcSEcCtD
Amoxapine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000107	0.000777	CcSEcCtD
Amoxapine—Constipation—Valsartan—type 2 diabetes mellitus	0.000106	0.000775	CcSEcCtD
Amoxapine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000106	0.000772	CcSEcCtD
Amoxapine—Hypotension—Metformin—type 2 diabetes mellitus	0.000106	0.000771	CcSEcCtD
Amoxapine—Shock—Irbesartan—type 2 diabetes mellitus	0.000105	0.000766	CcSEcCtD
Amoxapine—Olanzapine—CYP1A2—type 2 diabetes mellitus	0.000105	0.0355	CrCbGaD
Amoxapine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000764	CcSEcCtD
Amoxapine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000762	CcSEcCtD
Amoxapine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000104	0.00076	CcSEcCtD
Amoxapine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000758	CcSEcCtD
Amoxapine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000757	CcSEcCtD
Amoxapine—Tension—Ramipril—type 2 diabetes mellitus	0.000104	0.000756	CcSEcCtD
Amoxapine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000103	0.000754	CcSEcCtD
Amoxapine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000753	CcSEcCtD
Amoxapine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000103	0.000752	CcSEcCtD
Amoxapine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000103	0.000748	CcSEcCtD
Amoxapine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000103	0.000748	CcSEcCtD
Amoxapine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000742	CcSEcCtD
Amoxapine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.000741	CcSEcCtD
Amoxapine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000102	0.000741	CcSEcCtD
Amoxapine—Confusional state—Losartan—type 2 diabetes mellitus	0.000101	0.000739	CcSEcCtD
Amoxapine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000101	0.000738	CcSEcCtD
Amoxapine—Somnolence—Metformin—type 2 diabetes mellitus	0.000101	0.000734	CcSEcCtD
Amoxapine—Oedema—Losartan—type 2 diabetes mellitus	0.000101	0.000733	CcSEcCtD
Amoxapine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.0001	0.000732	CcSEcCtD
Amoxapine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.99e-05	0.000728	CcSEcCtD
Amoxapine—Dyspepsia—Metformin—type 2 diabetes mellitus	9.97e-05	0.000726	CcSEcCtD
Amoxapine—Tremor—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000721	CcSEcCtD
Amoxapine—Shock—Losartan—type 2 diabetes mellitus	9.89e-05	0.000721	CcSEcCtD
Amoxapine—Urticaria—Valsartan—type 2 diabetes mellitus	9.88e-05	0.00072	CcSEcCtD
Amoxapine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.85e-05	0.000718	CcSEcCtD
Amoxapine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.84e-05	0.000717	CcSEcCtD
Amoxapine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.83e-05	0.000716	CcSEcCtD
Amoxapine—Tachycardia—Losartan—type 2 diabetes mellitus	9.81e-05	0.000715	CcSEcCtD
Amoxapine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.79e-05	0.000714	CcSEcCtD
Amoxapine—Fatigue—Metformin—type 2 diabetes mellitus	9.76e-05	0.000711	CcSEcCtD
Amoxapine—Urticaria—Orlistat—type 2 diabetes mellitus	9.76e-05	0.000711	CcSEcCtD
Amoxapine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.71e-05	0.000708	CcSEcCtD
Amoxapine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.71e-05	0.000708	CcSEcCtD
Amoxapine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.71e-05	0.000708	CcSEcCtD
Amoxapine—Agitation—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000708	CcSEcCtD
Amoxapine—Constipation—Metformin—type 2 diabetes mellitus	9.68e-05	0.000706	CcSEcCtD
Amoxapine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000699	CcSEcCtD
Amoxapine—Anorexia—Losartan—type 2 diabetes mellitus	9.59e-05	0.000699	CcSEcCtD
Amoxapine—Vomiting—Glyburide—type 2 diabetes mellitus	9.58e-05	0.000698	CcSEcCtD
Amoxapine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.58e-05	0.000698	CcSEcCtD
Amoxapine—Rash—Glyburide—type 2 diabetes mellitus	9.5e-05	0.000693	CcSEcCtD
Amoxapine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000692	CcSEcCtD
Amoxapine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.49e-05	0.000692	CcSEcCtD
Amoxapine—Syncope—Ramipril—type 2 diabetes mellitus	9.48e-05	0.00069	CcSEcCtD
Amoxapine—Leukopenia—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000689	CcSEcCtD
Amoxapine—Headache—Glyburide—type 2 diabetes mellitus	9.44e-05	0.000688	CcSEcCtD
Amoxapine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.000685	CcSEcCtD
Amoxapine—Loxapine—ADRA2A—type 2 diabetes mellitus	9.41e-05	0.0317	CrCbGaD
Amoxapine—Hypotension—Losartan—type 2 diabetes mellitus	9.4e-05	0.000685	CcSEcCtD
Amoxapine—Palpitations—Ramipril—type 2 diabetes mellitus	9.34e-05	0.00068	CcSEcCtD
Amoxapine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.33e-05	0.00068	CcSEcCtD
Amoxapine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.29e-05	0.000677	CcSEcCtD
Amoxapine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.29e-05	0.000677	CcSEcCtD
Amoxapine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.26e-05	0.000675	CcSEcCtD
Amoxapine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.26e-05	0.000675	CcSEcCtD
Amoxapine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.21e-05	0.000671	CcSEcCtD
Amoxapine—Quetiapine—ADRA2A—type 2 diabetes mellitus	9.18e-05	0.031	CrCbGaD
Amoxapine—Convulsion—Ramipril—type 2 diabetes mellitus	9.15e-05	0.000667	CcSEcCtD
Amoxapine—Constipation—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000666	CcSEcCtD
Amoxapine—Insomnia—Losartan—type 2 diabetes mellitus	9.1e-05	0.000663	CcSEcCtD
Amoxapine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000658	CcSEcCtD
Amoxapine—Urticaria—Metformin—type 2 diabetes mellitus	9e-05	0.000656	CcSEcCtD
Amoxapine—Nausea—Glyburide—type 2 diabetes mellitus	8.95e-05	0.000652	CcSEcCtD
Amoxapine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.95e-05	0.000652	CcSEcCtD
Amoxapine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.95e-05	0.000652	CcSEcCtD
Amoxapine—Somnolence—Losartan—type 2 diabetes mellitus	8.94e-05	0.000652	CcSEcCtD
Amoxapine—Asthenia—Valsartan—type 2 diabetes mellitus	8.92e-05	0.00065	CcSEcCtD
Amoxapine—Dyspepsia—Losartan—type 2 diabetes mellitus	8.85e-05	0.000645	CcSEcCtD
Amoxapine—Asthenia—Orlistat—type 2 diabetes mellitus	8.82e-05	0.000642	CcSEcCtD
Amoxapine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000642	CcSEcCtD
Amoxapine—Pruritus—Valsartan—type 2 diabetes mellitus	8.8e-05	0.000641	CcSEcCtD
Amoxapine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000641	CcSEcCtD
Amoxapine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.74e-05	0.000637	CcSEcCtD
Amoxapine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000637	CcSEcCtD
Amoxapine—Confusional state—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000634	CcSEcCtD
Amoxapine—Pruritus—Orlistat—type 2 diabetes mellitus	8.69e-05	0.000633	CcSEcCtD
Amoxapine—Fatigue—Losartan—type 2 diabetes mellitus	8.67e-05	0.000632	CcSEcCtD
Amoxapine—Loxapine—HTR2C—type 2 diabetes mellitus	8.66e-05	0.0292	CrCbGaD
Amoxapine—Oedema—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000628	CcSEcCtD
Amoxapine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.61e-05	0.000627	CcSEcCtD
Amoxapine—Constipation—Losartan—type 2 diabetes mellitus	8.6e-05	0.000627	CcSEcCtD
Amoxapine—Rash—Gliclazide—type 2 diabetes mellitus	8.53e-05	0.000622	CcSEcCtD
Amoxapine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.53e-05	0.000621	CcSEcCtD
Amoxapine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.51e-05	0.00062	CcSEcCtD
Amoxapine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000619	CcSEcCtD
Amoxapine—Shock—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000618	CcSEcCtD
Amoxapine—Headache—Gliclazide—type 2 diabetes mellitus	8.48e-05	0.000618	CcSEcCtD
Amoxapine—Quetiapine—HTR2C—type 2 diabetes mellitus	8.45e-05	0.0285	CrCbGaD
Amoxapine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000616	CcSEcCtD
Amoxapine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000616	CcSEcCtD
Amoxapine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000615	CcSEcCtD
Amoxapine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000613	CcSEcCtD
Amoxapine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.41e-05	0.000613	CcSEcCtD
Amoxapine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.29e-05	0.000604	CcSEcCtD
Amoxapine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.22e-05	0.000599	CcSEcCtD
Amoxapine—Dizziness—Valsartan—type 2 diabetes mellitus	8.22e-05	0.000599	CcSEcCtD
Amoxapine—Anorexia—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000599	CcSEcCtD
Amoxapine—Dizziness—Orlistat—type 2 diabetes mellitus	8.13e-05	0.000592	CcSEcCtD
Amoxapine—Asthenia—Metformin—type 2 diabetes mellitus	8.12e-05	0.000592	CcSEcCtD
Amoxapine—Hypotension—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000587	CcSEcCtD
Amoxapine—Nausea—Gliclazide—type 2 diabetes mellitus	8.04e-05	0.000586	CcSEcCtD
Amoxapine—Pruritus—Metformin—type 2 diabetes mellitus	8.01e-05	0.000584	CcSEcCtD
Amoxapine—Urticaria—Losartan—type 2 diabetes mellitus	7.99e-05	0.000582	CcSEcCtD
Amoxapine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.95e-05	0.000579	CcSEcCtD
Amoxapine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.95e-05	0.000579	CcSEcCtD
Amoxapine—Vomiting—Valsartan—type 2 diabetes mellitus	7.91e-05	0.000576	CcSEcCtD
Amoxapine—Clozapine—ADRA2A—type 2 diabetes mellitus	7.9e-05	0.0266	CrCbGaD
Amoxapine—Rash—Valsartan—type 2 diabetes mellitus	7.84e-05	0.000571	CcSEcCtD
Amoxapine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000571	CcSEcCtD
Amoxapine—Vomiting—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000569	CcSEcCtD
Amoxapine—Insomnia—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000568	CcSEcCtD
Amoxapine—Headache—Valsartan—type 2 diabetes mellitus	7.79e-05	0.000568	CcSEcCtD
Amoxapine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.75e-05	0.000565	CcSEcCtD
Amoxapine—Rash—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000565	CcSEcCtD
Amoxapine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000564	CcSEcCtD
Amoxapine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.74e-05	0.000564	CcSEcCtD
Amoxapine—Headache—Orlistat—type 2 diabetes mellitus	7.7e-05	0.000561	CcSEcCtD
Amoxapine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000559	CcSEcCtD
Amoxapine—Somnolence—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000559	CcSEcCtD
Amoxapine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000553	CcSEcCtD
Amoxapine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.000551	CcSEcCtD
Amoxapine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000546	CcSEcCtD
Amoxapine—Dizziness—Metformin—type 2 diabetes mellitus	7.49e-05	0.000546	CcSEcCtD
Amoxapine—Chlordiazepoxide—CYP3A4—type 2 diabetes mellitus	7.44e-05	0.0251	CrCbGaD
Amoxapine—Fatigue—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000542	CcSEcCtD
Amoxapine—Nausea—Valsartan—type 2 diabetes mellitus	7.39e-05	0.000538	CcSEcCtD
Amoxapine—Constipation—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000537	CcSEcCtD
Amoxapine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.000533	CcSEcCtD
Amoxapine—Nausea—Orlistat—type 2 diabetes mellitus	7.3e-05	0.000532	CcSEcCtD
Amoxapine—Clozapine—HTR2C—type 2 diabetes mellitus	7.27e-05	0.0245	CrCbGaD
Amoxapine—Asthenia—Losartan—type 2 diabetes mellitus	7.22e-05	0.000526	CcSEcCtD
Amoxapine—Vomiting—Metformin—type 2 diabetes mellitus	7.2e-05	0.000525	CcSEcCtD
Amoxapine—Rash—Metformin—type 2 diabetes mellitus	7.14e-05	0.00052	CcSEcCtD
Amoxapine—Dermatitis—Metformin—type 2 diabetes mellitus	7.13e-05	0.00052	CcSEcCtD
Amoxapine—Pruritus—Losartan—type 2 diabetes mellitus	7.11e-05	0.000518	CcSEcCtD
Amoxapine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000518	CcSEcCtD
Amoxapine—Headache—Metformin—type 2 diabetes mellitus	7.09e-05	0.000517	CcSEcCtD
Amoxapine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000515	CcSEcCtD
Amoxapine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000514	CcSEcCtD
Amoxapine—Olanzapine—CYP3A4—type 2 diabetes mellitus	6.96e-05	0.0235	CrCbGaD
Amoxapine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.88e-05	0.000501	CcSEcCtD
Amoxapine—Urticaria—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000499	CcSEcCtD
Amoxapine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000497	CcSEcCtD
Amoxapine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000497	CcSEcCtD
Amoxapine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000495	CcSEcCtD
Amoxapine—Rash—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000491	CcSEcCtD
Amoxapine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000491	CcSEcCtD
Amoxapine—Nausea—Metformin—type 2 diabetes mellitus	6.73e-05	0.00049	CcSEcCtD
Amoxapine—Headache—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000488	CcSEcCtD
Amoxapine—Dizziness—Losartan—type 2 diabetes mellitus	6.65e-05	0.000485	CcSEcCtD
Amoxapine—Vomiting—Losartan—type 2 diabetes mellitus	6.39e-05	0.000466	CcSEcCtD
Amoxapine—Nausea—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000463	CcSEcCtD
Amoxapine—Rash—Losartan—type 2 diabetes mellitus	6.34e-05	0.000462	CcSEcCtD
Amoxapine—Dermatitis—Losartan—type 2 diabetes mellitus	6.33e-05	0.000462	CcSEcCtD
Amoxapine—Headache—Losartan—type 2 diabetes mellitus	6.3e-05	0.000459	CcSEcCtD
Amoxapine—Asthenia—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000451	CcSEcCtD
Amoxapine—Pruritus—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000445	CcSEcCtD
Amoxapine—Olanzapine—ALB—type 2 diabetes mellitus	6.07e-05	0.0205	CrCbGaD
Amoxapine—Nausea—Losartan—type 2 diabetes mellitus	5.97e-05	0.000435	CcSEcCtD
Amoxapine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.9e-05	0.00043	CcSEcCtD
Amoxapine—Diazepam—CYP2E1—type 2 diabetes mellitus	5.84e-05	0.0197	CrCbGaD
Amoxapine—Clozapine—CYP2E1—type 2 diabetes mellitus	5.77e-05	0.0195	CrCbGaD
Amoxapine—Dizziness—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000416	CcSEcCtD
Amoxapine—Diazepam—CYP1A2—type 2 diabetes mellitus	5.56e-05	0.0187	CrCbGaD
Amoxapine—Clozapine—CYP1A2—type 2 diabetes mellitus	5.49e-05	0.0185	CrCbGaD
Amoxapine—Vomiting—Ramipril—type 2 diabetes mellitus	5.48e-05	0.0004	CcSEcCtD
Amoxapine—Rash—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000396	CcSEcCtD
Amoxapine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000396	CcSEcCtD
Amoxapine—Headache—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000394	CcSEcCtD
Amoxapine—Estazolam—CYP3A4—type 2 diabetes mellitus	5.39e-05	0.0182	CrCbGaD
Amoxapine—Nausea—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000373	CcSEcCtD
Amoxapine—Prazepam—CYP3A4—type 2 diabetes mellitus	4.96e-05	0.0168	CrCbGaD
Amoxapine—Oxazepam—CYP3A4—type 2 diabetes mellitus	4.48e-05	0.0151	CrCbGaD
Amoxapine—Temazepam—CYP3A4—type 2 diabetes mellitus	4.43e-05	0.0149	CrCbGaD
Amoxapine—Quetiapine—CYP3A4—type 2 diabetes mellitus	4.22e-05	0.0142	CrCbGaD
Amoxapine—Diazepam—CYP3A4—type 2 diabetes mellitus	3.68e-05	0.0124	CrCbGaD
Amoxapine—Clozapine—CYP3A4—type 2 diabetes mellitus	3.63e-05	0.0123	CrCbGaD
Amoxapine—Diazepam—ALB—type 2 diabetes mellitus	3.21e-05	0.0108	CrCbGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.03e-06	2.08e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.02e-06	2.08e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.02e-06	2.07e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2e-06	2.06e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2e-06	2.06e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2e-06	2.05e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.99e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.99e-06	2.05e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.99e-06	2.04e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.96e-06	2.02e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.96e-06	2.01e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	1.95e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.95e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.95e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SRC—type 2 diabetes mellitus	1.95e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	1.94e-06	2e-05	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.94e-06	1.99e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.94e-06	1.99e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.94e-06	1.99e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.94e-06	1.99e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.93e-06	1.98e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.93e-06	1.98e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.92e-06	1.98e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.92e-06	1.97e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.92e-06	1.97e-05	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.92e-06	1.97e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	1.91e-06	1.97e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.91e-06	1.97e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.91e-06	1.96e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.91e-06	1.96e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.91e-06	1.96e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.9e-06	1.95e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.9e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.9e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.89e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.89e-06	1.94e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.89e-06	1.94e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.89e-06	1.94e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.89e-06	1.94e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.89e-06	1.94e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.88e-06	1.94e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.88e-06	1.93e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.88e-06	1.93e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.88e-06	1.93e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.87e-06	1.92e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	1.86e-06	1.91e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.86e-06	1.91e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.86e-06	1.91e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.85e-06	1.91e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.85e-06	1.91e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.85e-06	1.9e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.85e-06	1.9e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.85e-06	1.9e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.85e-06	1.9e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.85e-06	1.9e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.84e-06	1.9e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.84e-06	1.89e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.84e-06	1.89e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.84e-06	1.89e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.83e-06	1.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.83e-06	1.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.83e-06	1.88e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.82e-06	1.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.82e-06	1.87e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.82e-06	1.87e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.82e-06	1.87e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.82e-06	1.87e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.81e-06	1.86e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.81e-06	1.86e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.81e-06	1.86e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.8e-06	1.85e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.79e-06	1.84e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.79e-06	1.84e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.78e-06	1.83e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.78e-06	1.83e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.77e-06	1.82e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.76e-06	1.81e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.76e-06	1.81e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.76e-06	1.81e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.75e-06	1.8e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.75e-06	1.79e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.74e-06	1.79e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.74e-06	1.79e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.74e-06	1.79e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.73e-06	1.78e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.73e-06	1.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.72e-06	1.77e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.71e-06	1.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.71e-06	1.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.71e-06	1.76e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.71e-06	1.75e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.7e-06	1.75e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.69e-06	1.74e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.69e-06	1.74e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.69e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.68e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.68e-06	1.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.68e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.68e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.68e-06	1.73e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.68e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.68e-06	1.72e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-06	1.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.67e-06	1.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.67e-06	1.72e-05	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.67e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.66e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.66e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.66e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.65e-06	1.7e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.65e-06	1.7e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.65e-06	1.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.65e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.65e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.64e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.63e-06	1.68e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.63e-06	1.68e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.63e-06	1.68e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.63e-06	1.67e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.61e-06	1.65e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.61e-06	1.65e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.6e-06	1.65e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.6e-06	1.64e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.59e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.59e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.58e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.58e-06	1.62e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.58e-06	1.62e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.57e-06	1.62e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.56e-06	1.61e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.56e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.55e-06	1.6e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.55e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.55e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.54e-06	1.58e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.53e-06	1.57e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.53e-06	1.57e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.52e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.51e-06	1.55e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.5e-06	1.54e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.48e-06	1.52e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.47e-06	1.51e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.47e-06	1.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.45e-06	1.49e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.45e-06	1.49e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.44e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.44e-06	1.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.44e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.44e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.44e-06	1.48e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.43e-06	1.47e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.43e-06	1.47e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.43e-06	1.47e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.43e-06	1.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.42e-06	1.46e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.42e-06	1.46e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.42e-06	1.46e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.41e-06	1.45e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.41e-06	1.45e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.4e-06	1.44e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.4e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.4e-06	1.43e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.39e-06	1.43e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.39e-06	1.43e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.37e-06	1.41e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.36e-06	1.4e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.36e-06	1.4e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.35e-06	1.39e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.35e-06	1.38e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.34e-06	1.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.34e-06	1.37e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.33e-06	1.37e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.33e-06	1.37e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.33e-06	1.37e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.32e-06	1.36e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.31e-06	1.35e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.31e-06	1.35e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.31e-06	1.35e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.31e-06	1.35e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.31e-06	1.34e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.31e-06	1.34e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.3e-06	1.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.3e-06	1.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.29e-06	1.33e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.29e-06	1.32e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.28e-06	1.32e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-06	1.32e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.27e-06	1.31e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.27e-06	1.3e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-06	1.3e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-06	1.29e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.25e-06	1.29e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.25e-06	1.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.24e-06	1.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.24e-06	1.28e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.24e-06	1.27e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.23e-06	1.27e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.23e-06	1.26e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.22e-06	1.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-06	1.25e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.21e-06	1.25e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.21e-06	1.24e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.21e-06	1.24e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.21e-06	1.24e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.21e-06	1.24e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-06	1.23e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.19e-06	1.23e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.19e-06	1.23e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.19e-06	1.22e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.19e-06	1.22e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.18e-06	1.21e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.16e-06	1.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.13e-06	1.16e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.13e-06	1.16e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.13e-06	1.16e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.11e-06	1.14e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-06	1.14e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-06	1.14e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.11e-06	1.14e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-06	1.14e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	1.13e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.1e-06	1.13e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-06	1.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-06	1.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.09e-06	1.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-06	1.12e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-06	1.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.07e-06	1.1e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	1.07e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.03e-06	1.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-06	1.04e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.93e-07	1.02e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	9.71e-07	9.98e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	9.66e-07	9.92e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.95e-07	9.2e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.91e-07	9.16e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.52e-07	8.76e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	8.42e-07	8.65e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.39e-07	8.62e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.37e-07	8.6e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.34e-07	8.57e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.21e-07	8.44e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.86e-07	8.08e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.74e-07	7.95e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.72e-07	7.93e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.69e-07	7.91e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.63e-07	7.84e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.57e-07	7.78e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.04e-07	7.23e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.48e-07	5.64e-06	CbGpPWpGaD
